Sensus Healthcare (SRTS)
(Delayed Data from NSDQ)
$3.65 USD
-0.21 (-5.44%)
Updated May 3, 2024 04:00 PM ET
After-Market: $3.70 +0.05 (1.37%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth C Momentum D VGM
Brokerage Reports
0 items in cart
Sensus Healthcare, Inc. [SRTS]
Reports for Purchase
Showing records 61 - 80 ( 98 total )
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
1Q20 Financial Results Reported; Reiterate Buy; Lowering PT to $5
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
4Q19 and Full-Year 2019 Financials Reported; Reiterate Buy; Lowering PT to $8
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
2Q19 Results Reported: Bottom-Line Beat; Reiterate Buy; Raising PT to $10
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
1Q19 Financial Results Reported; Reiterate Buy; Lowering Price Target to $9
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
1Q19 Recap - Rough Quarter, but Business Model Appears Intact
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Superficial Radiation Therapy Delivers 98.9% Cure Rate in Five-Year Study; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
IORT System Secures FDA Clearance; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
4Q18 Recap - Strong Growth Should Continue in 2019
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Full-Year 2018 Financial Results Reported; Reiterate Buy and Raise Price Target to $13
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R